BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30333538)

  • 1. Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study.
    Scharl S; Barthel C; Rossel JB; Biedermann L; Misselwitz B; Schoepfer AM; Straumann A; Vavricka SR; Rogler G; Scharl M; Greuter T
    Am J Gastroenterol; 2019 Jan; 114(1):116-126. PubMed ID: 30333538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre Experience.
    Madanchi M; Zeitz J; Barthel C; Samaras P; Scharl S; Sulz MC; Biedermann L; Frei P; Vavricka SR; Rogler G; Scharl M
    Digestion; 2016; 94(1):1-8. PubMed ID: 27318857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients.
    Khan N; Vallarino C; Lissoos T; Darr U; Luo M
    Drugs Aging; 2017 Nov; 34(11):859-868. PubMed ID: 29170864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Malignant Cancers in Inflammatory Bowel Disease.
    Loo SY; Vutcovici M; Bitton A; Lakatos PL; Azoulay L; Suissa S; Brassard P
    J Crohns Colitis; 2019 Sep; 13(10):1302-1310. PubMed ID: 30874294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of malignancy in patients with inflammatory bowel disease: A population-based cohort study from China.
    Zhang H; Zhang M; Chen X; Guo M; Zhou R; Lv H; Li Y; Tan B; Li J; Xu H; Zheng W; Yang H; Qian J
    Int J Cancer; 2022 Jun; 150(11):1770-1778. PubMed ID: 35037241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher Risk for Hematological Malignancies in Inflammatory Bowel Disease: A Nationwide Population-based Study in Taiwan.
    Wang LH; Yang YJ; Cheng WC; Wang WM; Lin SH; Shieh CC
    Am J Gastroenterol; 2016 Sep; 111(9):1313-9. PubMed ID: 27296944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
    Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
    Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
    J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Lymphoma, Colorectal and Skin Cancer in Patients with IBD Treated with Immunomodulators and Biologics: A Quebec Claims Database Study.
    Kopylov U; Vutcovici M; Kezouh A; Seidman E; Bitton A; Afif W
    Inflamm Bowel Dis; 2015 Aug; 21(8):1847-53. PubMed ID: 25993693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN; Nugent Z; Blanchard JF
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
    Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
    Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
    Kotlyar DS; Lewis JD; Beaugerie L; Tierney A; Brensinger CM; Gisbert JP; Loftus EV; Peyrin-Biroulet L; Blonski WC; Van Domselaar M; Chaparro M; Sandilya S; Bewtra M; Beigel F; Biancone L; Lichtenstein GR
    Clin Gastroenterol Hepatol; 2015 May; 13(5):847-58.e4; quiz e48-50. PubMed ID: 24879926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
    Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
    Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based study examining the risk of malignancy in patients diagnosed with inflammatory bowel disease.
    Wilson JC; Furlano RI; Jick SS; Meier CR
    J Gastroenterol; 2016 Nov; 51(11):1050-1062. PubMed ID: 27056729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study.
    Jess T; Horváth-Puhó E; Fallingborg J; Rasmussen HH; Jacobsen BA
    Am J Gastroenterol; 2013 Dec; 108(12):1869-76. PubMed ID: 23978954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.
    So J; Tang W; Leung WK; Li M; Lo FH; Wong MTL; Sze ASF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Lam TY; Lam V; Lee TW; Lo HHH; Tang CM; Wong CL; Wu JCY; Chan FKL; Sung JJY; Harbord M; Ng SC
    Inflamm Bowel Dis; 2017 Nov; 23(11):2061-2068. PubMed ID: 28991855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Bowel Disease and the Risk of Autoimmune Diseases.
    Wilson JC; Furlano RI; Jick SS; Meier CR
    J Crohns Colitis; 2016 Feb; 10(2):186-93. PubMed ID: 26507860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study.
    Askling J; Dickman PW; Karlén P; Broström O; Lapidus A; Löfberg R; Ekbom A
    Lancet; 2001 Jan; 357(9252):262-6. PubMed ID: 11214128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU.
    Chaparro M; Garre A; Ricart E; Iglesias-Flores E; Taxonera C; Domènech E; Gisbert JP;
    Aliment Pharmacol Ther; 2019 Feb; 49(4):419-428. PubMed ID: 30637837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.